Literature DB >> 18228036

Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels.

Wolfram Kessler1, Thomas Budde, Michael Gekle, Anke Fabian, Albrecht Schwab.   

Abstract

Tumor cell migration is crucial for the formation of tumor metastases and the progression of tumor disease. Fibroblast growth factor-2 (FGF-2) is one of the cytokines involved in the autocrine stimulation of tumor development. FGF-2 also stimulates transcription of Ca(2+)-sensitive K(+) channels (IK1 or K(Ca)3.1), which are part of the migration machinery in many cell types. Here, we tested whether FGF-2 acutely stimulates migration of transformed MDCK cells in a K(Ca)3.1 channel-dependent way. FGF-2 accelerates migration dose dependently. The speed of migration increases almost instantaneously. After 2 min, ERK1/2 phosphorylation has almost doubled. FGF-2 does not stimulate migration when ERK1/2 phosphorylation is inhibited. K(Ca)3.1 channel blockade also prevents the stimulatory effect of FGF-2 on cell migration. In addition, FGF-2 treatment leads to an activation of K(Ca)3.1 channels and a rapid rise of the cell area, which is because of an elevated rate of exocytosis. However, the amount of K(Ca)3.1 channels within the plasma membrane does not change. Our results show that there is a reciprocal interrelation between FGF-2 and K(Ca)3.1 channels. K(Ca)3.1 channels that are under the transcriptional control of FGF-2 are part of the FGF-2-mediated signaling cascade leading to an acceleration of migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18228036     DOI: 10.1007/s00424-008-0452-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  54 in total

1.  A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.

Authors:  Kimita Suyama; Irina Shapiro; Mitchell Guttman; Rachel B Hazan
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

2.  K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.

Authors:  Heike Wulff; Hans-Günther Knaus; Michael Pennington; K George Chandy
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 3.  Role of the Na/H exchanger NHE1 in cell migration.

Authors:  C Stock; A Schwab
Journal:  Acta Physiol (Oxf)       Date:  2006 May-Jun       Impact factor: 6.311

4.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 5.  Cell migration in tumors.

Authors:  Hideki Yamaguchi; Jeffrey Wyckoff; John Condeelis
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

6.  Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.

Authors:  Ralf Köhler; Heike Wulff; Ines Eichler; Marlene Kneifel; Daniel Neumann; Andrea Knorr; Ivica Grgic; Doris Kämpfe; Han Si; Judith Wibawa; Robert Real; Klaus Borner; Susanne Brakemeier; Hans-Dieter Orzechowski; Hans-Peter Reusch; Martin Paul; K George Chandy; Joachim Hoyer
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

7.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

Authors:  M Nguyen; H Watanabe; A E Budson; J P Richie; D F Hayes; J Folkman
Journal:  J Natl Cancer Inst       Date:  1994-03-02       Impact factor: 13.506

Review 8.  Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective.

Authors:  Ashok K Pullikuth; Andrew D Catling
Journal:  Cell Signal       Date:  2007-05-05       Impact factor: 4.315

9.  VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.

Authors:  Serena Pillozzi; Maria Felice Brizzi; Pietro Antonio Bernabei; Benedetta Bartolozzi; Roberto Caporale; Venere Basile; Vieri Boddi; Luigi Pegoraro; Andrea Becchetti; Annarosa Arcangeli
Journal:  Blood       Date:  2007-04-09       Impact factor: 22.113

10.  Fibroblast growth factor-2 and remodeled type I collagen control membrane protrusion in human vascular smooth muscle cells: biphasic activation of Rac1.

Authors:  Euridiky Fera; Caroline O'Neil; Wilfred Lee; Shaohua Li; J Geoffrey Pickering
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  9 in total

Review 1.  Evidence of K+ channel function in epithelial cell migration, proliferation, and repair.

Authors:  Alban Girault; Emmanuelle Brochiero
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

2.  Mechanosensitive Ca(2+) permeant cation channels in human prostate tumor cells.

Authors:  Rosario Maroto; Alexander Kurosky; Owen P Hamill
Journal:  Channels (Austin)       Date:  2012-07-01       Impact factor: 2.581

3.  Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel 1.

Authors:  Anke Fabian; Thomas Fortmann; Etmar Bulk; Valerie C Bomben; Harald Sontheimer; Albrecht Schwab
Journal:  Pflugers Arch       Date:  2010-12-01       Impact factor: 3.657

Review 4.  Ion channels and apoptosis in cancer.

Authors:  Carl D Bortner; John A Cidlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

Review 5.  The role of Lipoxin A4 in Cystic Fibrosis Lung Disease.

Authors:  Valérie Urbach; Gerard Higgins; Paul Buchanan; Fiona Ringholz
Journal:  Comput Struct Biotechnol J       Date:  2013-12-06       Impact factor: 7.271

Review 6.  Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.

Authors:  Gerard Higgins; Fiona Ringholz; Paul Buchanan; Paul McNally; Valérie Urbach
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 7.  Ion channels or aquaporins as novel molecular targets in gastric cancer.

Authors:  Jianling Xia; Hongqiang Wang; Shi Li; Qinghui Wu; Li Sun; Hongxiang Huang; Ming Zeng
Journal:  Mol Cancer       Date:  2017-03-06       Impact factor: 27.401

Review 8.  Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments.

Authors:  Harry J Gould; Dennis Paul
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

9.  FGF23 promotes renal calcium reabsorption through the TRPV5 channel.

Authors:  Olena Andrukhova; Alina Smorodchenko; Monika Egerbacher; Carmen Streicher; Ute Zeitz; Regina Goetz; Victoria Shalhoub; Moosa Mohammadi; Elena E Pohl; Beate Lanske; Reinhold G Erben
Journal:  EMBO J       Date:  2014-01-16       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.